Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CDNA – CareDx, Inc

Float Short %

14.21

Margin Of Safety %

-35

Put/Call OI Ratio

0.31

EPS Next Q Diff

-0.07

EPS Last/This Y

-0.31

EPS This/Next Y

0.19

Price

19.91

Target Price

23.67

Analyst Recom

1.89

Performance Q

40.41

Relative Volume

0.97

Beta

2.47

Ticker: CDNA



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-17CDNA15.510.340.413111
2025-11-18CDNA15.760.34999.993103
2025-11-19CDNA15.980.340.203105
2025-11-20CDNA15.760.330.013210
2025-11-21CDNA17.160.320.003236
2025-11-24CDNA17.960.330.022120
2025-11-25CDNA17.90.320.002165
2025-11-26CDNA17.830.320.002182
2025-12-01CDNA17.20.320.002186
2025-12-02CDNA17.440.310.002197
2025-12-03CDNA18.860.310.002197
2025-12-04CDNA19.420.310.002237
2025-12-05CDNA18.530.300.002285
2025-12-08CDNA18.910.300.002285
2025-12-09CDNA19.270.290.062313
2025-12-10CDNA19.520.290.032323
2025-12-11CDNA19.810.300.002319
2025-12-12CDNA20.570.300.032293
2025-12-15CDNA19.920.310.002270
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-17CDNA15.5129.6- 0.70
2025-11-18CDNA15.7529.6- 0.69
2025-11-19CDNA15.9829.6- 0.69
2025-11-20CDNA15.7729.6- 0.69
2025-11-21CDNA17.1925.9- 0.69
2025-11-24CDNA17.9725.9- 0.69
2025-11-25CDNA17.9025.9- 0.69
2025-11-26CDNA17.8325.9- 0.69
2025-12-01CDNA17.1925.9- 0.69
2025-12-02CDNA17.4425.9- 0.69
2025-12-03CDNA18.8525.9- 0.69
2025-12-04CDNA19.4325.9- 0.69
2025-12-05CDNA18.5325.9- 0.69
2025-12-08CDNA18.9025.9- 0.69
2025-12-09CDNA19.2525.9- 0.69
2025-12-10CDNA19.2525.9- 0.69
2025-12-11CDNA19.8025.9- 0.69
2025-12-12CDNA20.5725.9- 0.69
2025-12-15CDNA19.9125.9- 0.69
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1



19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-17CDNA-2.87-5.0613.54
2025-11-18CDNA-2.86-5.0613.54
2025-11-19CDNA-2.86-5.0613.54
2025-11-20CDNA-2.86-5.0613.54
2025-11-21CDNA-2.86-5.0613.54
2025-11-24CDNA-2.86-3.5914.15
2025-11-25CDNA-1.67-3.5914.15
2025-11-26CDNA-1.67-3.5915.00
2025-12-01CDNA-1.09-3.1415.00
2025-12-02CDNA-1.09-3.1415.00
2025-12-03CDNA-1.09-3.1415.00
2025-12-04CDNA-1.09-3.1415.00
2025-12-05CDNA-1.23-3.1415.00
2025-12-08CDNA-1.23-2.9715.00
2025-12-09CDNA-1.23-2.9715.00
2025-12-10CDNA-1.23-2.9714.16
2025-12-11CDNA-1.23-2.9714.16
2025-12-12CDNA-1.23-2.9714.16
2025-12-15CDNA-0.85-3.0014.21
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="CDNA" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS​

0.28

Avg. EPS Est. Current Quarter

0.23

Avg. EPS Est. Next Quarter

0.21

Insider Transactions

-0.85

Institutional Transactions

-3

Beta

2.47

Average Sales Estimate Current Quarter

102

Average Sales Estimate Next Quarter

100

Fair Value

12.85

Quality Score

85

Growth Score

50

Sentiment Score

62

Actual DrawDown %

80.1

Max Drawdown 5-Year %

-94.9

Target Price

23.67

P/E

16.7

Forward P/E

PEG

P/S

2.86

P/B

3.29

P/Free Cash Flow

27.61

EPS

1.19

Average EPS Est. Cur. Y​

0.69

EPS Next Y. (Est.)

0.87

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

19.68

Relative Volume

0.97

Return on Equity vs Sector %

-4.4

Return on Equity vs Industry %

11.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.15

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”CDNA” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CDNA” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CDNA” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CDNA” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CDNA” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CDNA” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”CDNA” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
CareDx, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 644
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI, a transplant quality tracking software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
stock quote shares CDNA – CareDx, Inc Stock Price stock today
news today CDNA – CareDx, Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch CDNA – CareDx, Inc yahoo finance google finance
stock history CDNA – CareDx, Inc invest stock market
stock prices CDNA premarket after hours
ticker CDNA fair value insiders trading